VDRM2 significantly reduces TMPRSS2:ERG positive VCaP xenograft tumor growth without causing hypercalcemia or significant weight loss in mice and VDRM2 is stable in cells that overexpress CYP24A1. This evidence concerns the gene ERG and neoplasm.